Cargando…

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study

Objective To compare the risk of acute myocardial infarction, heart failure, and death in patients with type 2 diabetes treated with rosiglitazone and pioglitazone. Design Retrospective cohort study. Setting Ontario, Canada. Participants Outpatients aged 66 years and older who were started on rosigl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juurlink, David N, Gomes, Tara, Lipscombe, Lorraine L, Austin, Peter C, Hux, Janet E, Mamdani, Muhammad M
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728804/ https://www.ncbi.nlm.nih.gov/pubmed/19690342 http://dx.doi.org/10.1136/bmj.b2942

Ejemplares similares

Maternal opioid treatment after delivery and risk of adverse infant outcomes: population based cohort study
por: Zipursky, Jonathan S, et al.
Publicado: (2023)

Assessment of Stimulant Use and Cardiovascular Event Risks Among Older Adults
por: Tadrous, Mina, et al.
Publicado: (2021)

Statins and the Risk of Herpes Zoster: A Population-Based Cohort Study
por: Antoniou, Tony, et al.
Publicado: (2014)

Rosiglitazone and Pioglitazone Alter Aromatase Kinetic Properties in Human Granulosa Cells
por: Araki, Takako, et al.
Publicado: (2011)

Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings
por: Niyomnaitham, Suvimol, et al.
Publicado: (2014)

Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study
por: Antoniou, Tony, et al.
Publicado: (2015)

Rosiglitazone and Pioglitazone Utilization from January 2007 Through May 2008 Associated With Five Risk-Warning Events
por: Starner, Catherine I., et al.
Publicado: (2008)

Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study
por: Kaplovitch, Eric, et al.
Publicado: (2015)

Prescription of oxycodone versus codeine after childbirth and risk of persistent opioid use: a population-based cohort study
por: Zipursky, Jonathan S., et al.
Publicado: (2023)

Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Rosiglitazone use and associated adverse event rates in Canada: an updated analysis
por: Iczkovitz, Sandra, et al.
Publicado: (2015)

Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study
por: Pasricha, Sachin V., et al.
Publicado: (2018)

Utilization and Costs for Compliant Patients Initiating Therapy With Pioglitazone or Rosiglitazone Versus Insulin in a Medicaid Fee-for-Service Population
por: Kalsekar, Iftekhar, et al.
Publicado: (2006)

Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies
por: Deeg, Mark A., et al.
Publicado: (2008)

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database
por: Berthet, Stephanie, et al.
Publicado: (2011)

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
por: Colhoun, H. M., et al.
Publicado: (2012)

Influence of health warnings on the use of rosiglitazone and pioglitazone in an area of Spain: A time-series study
por: Carracedo-Martínez, Eduardo, et al.
Publicado: (2016)

Development of Heart Failure in Medicaid Patients with Type 2 Diabetes Treated with Pioglitazone, Rosiglitazone, or Metformin
por: Breunig, Ian M., et al.
Publicado: (2014)

Rosiglitazone use and associated adverse event rates in Canada between 2004 and 2010
por: Rawson, Nigel SB, et al.
Publicado: (2013)

Inequities in access to primary care among opioid recipients in Ontario, Canada: A population-based cohort study
por: Gomes, Tara, et al.
Publicado: (2021)

Proton Pump Inhibitors and the Risk of Adverse Cardiac Events
por: Juurlink, David N., et al.
Publicado: (2013)

Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats
por: Rao, Ravi Prakash, et al.
Publicado: (2011)

All-Cause Mortality and Serious Cardiovascular Events in People with Hip and Knee Osteoarthritis: A Population Based Cohort Study
por: Hawker, Gillian A., et al.
Publicado: (2014)

Risk of incident diabetes among patients treated with statins: population based study
por: Carter, Aleesa A, et al.
Publicado: (2013)

The Impact of Drug Reimbursement Policy on Rates of Testosterone Replacement Therapy among Older Men
por: Piszczek, Jolanta, et al.
Publicado: (2014)

The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety
por: Leonard, Charles E., et al.
Publicado: (2020)

High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study
por: Spooner, Luke, et al.
Publicado: (2016)

Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study
por: Fralick, Michael, et al.
Publicado: (2014)

Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case–control study
por: Gomes, Tara, et al.
Publicado: (2017)

Association of Pioglitazone With Major Adverse Cardiovascular Events, All-Cause Mortality, and Heart Failure Hospitalizations: A Systematic Review
por: Sheikh, Ibrahimkhalil M, et al.
Publicado: (2023)

Extended-release nifedipine and the risk of intestinal obstruction: a population-based study
por: Juurlink, David N, et al.
Publicado: (2014)

The Burden of Opioid-Related Mortality in the United States
por: Gomes, Tara, et al.
Publicado: (2018)

Changing patterns of opioid initiation for pain management in Ontario, Canada: A population-based cross-sectional study
por: Gomes, Tara, et al.
Publicado: (2022)

Adverse drug effects observed with vildagliptin versus pioglitazone or rosiglitazone in the treatment of patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
por: Piccinni, Carlo, et al.
Publicado: (2011)

Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population‐based time–series analysis
por: Antoniou, Tony, et al.
Publicado: (2021)

Reformulation of controlled-release oxycodone and pharmacy dispensing patterns near the US–Canada border
por: Gomes, Tara, et al.
Publicado: (2012)

The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation
por: Sholzberg, Michelle, et al.
Publicado: (2016)

Interprovincial Variation of Psychotropic Prescriptions Dispensed to Older Canadian Adults
por: Black, Cody D., et al.
Publicado: (2018)

Trends in Opioid Toxicity–Related Deaths in the US Before and After the Start of the COVID-19 Pandemic, 2011-2021
por: Gomes, Tara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mc3qp2cnuu31avg76uc0t6t51u